Gabrielle
@GRocqueMD
Followers
566
Following
2K
Media
147
Statuses
746
Joined December 2012
#ASCOQLTY24 @DrLolaFayanju giving a MASTER CLASS on how to think about collecting health related social risks/needs data in an evidence-based way... all leading to the launch of her trial NCT06019988 assessing HRSR, SDoH and enhanced navigation.
0
4
32
We present the 1st national study on how unprepared HCWs feel in legal counseling & how a structured legal literacy intervention improved their skills. Congrats to star mentee Krista Chen MS4 & @TriageCancer, w/ Krista receiving an @ASCO Merit Award! #ASCOQLTY24 @ONealCancerUAB
1
5
35
"Focusing on the patient experience is a powerful driver. We are all aligned in our ultimate goal. Patient-centered care is good business." Dr @EthanBasch1 the Joe Simone Award lecture at @ASCO #ASCOQLTY24
"On the Verge of a Golden Age in Quality Cancer Care" Dr @EthanBasch1 receives the Joe Simone Award @ASCO #ASCOQLTY24 for his career developing the field of patient reported outcomes to improve patient-centered care.
2
18
48
Congrats to @NicoleFleege who presented her work today on disparities in mental health screening in veteran woman with breast cancer. #ASCOQLTY24 @UIowaCancer @GRocqueMD
0
5
25
Amazing talk by Natalie Dickson and their great program. Well done! #ASCOQLTY24
Dr Natalie R. Dickson @TNOncology discusses a patient navigation program #ASCOQLTY24: how to build it, how to sustain it, and how to measure appropriate outcomes.
0
0
6
Congrats @EthanBasch1! Well deserved!!
We're pleased to honor Ethan Basch, MD, MSc, FASCO, with the Joseph Simone Quality Care Award at #ASCOQLTY24. Read more: https://t.co/JGUH2tWbKQ
@Ethanbasch1
0
0
16
0
0
8
Very happy to see this one in press, we will need new strategies to engage diverse populations in #ePROs
https://t.co/6esWm5aIlH
2
4
13
Oncologist review of #ePROs in treatment decision-making can support patient-centered care. Thank you @AmericanCancer for supporting this work! @ONealCancerUAB
https://t.co/TRObwExsbf
link.springer.com
Breast Cancer Research and Treatment - Opportunities exist for patients with metastatic breast cancer (MBC) to engage in shared decision-making (SDM). Presenting patient-reported data, including...
0
1
9
Louder for those in the back! Research is only meaningful if it can equitable reach the populations it is supposed to serve. Thank you Dr. Krzynzanowska for this nuances discussion. #ASCO24 @ASCO @HemOncWomenDocs #CareDelivery #Policy #ImplementationScience cc: @GRocqueMD
1
4
13
In an editorial published in @JAMA_current, @StephWheelerUNC, PhD, MPH, and colleagues endorse the use of simulation models to assess the impact of cancer control initiatives. @ethanbasch1 @GRocqueMD
unclineberger.org
In a JAMA editorial, Stephanie Wheeler and colleagues endorse the use of simulation models to assess the impact of cancer control initiatives.
0
3
9
Unpacking oncologist psychology around #optimization (reducing chemotherapy) in #cancer is fascinating @awolff @LaurenWallner @LynneWagnerPhD @ONealCancerUAB
Excited to announce that one of my favorite articles I've ever written has been published 🤗 @GRocqueMD Come read about why optimization-focused clinical trials in cancer care are necessary yet psychologically tricky for oncologists! https://t.co/byxekyBt1o
0
1
8
If there is only one thing you need to learn from #ascoqlty23, it's navigation works. Now CMS is ready to pay according to the latest news! @RyanNipp @GRocqueMD @ramy
https://t.co/VLGjDfjhdi
0
2
16
It’s a wrap. Great friends, great science, great leadership @cardismith #ASCOQLTY23
2
1
24
Incredible perspective by patient advocate @coffeemommy on MCED testing. We need more people like her participating in discussions. #ASCOQLTY23
1
4
10
Such a thoughtful discussion of engaging patients with serious mental illness and cancer by @KellyIrwin_MD #ASCOQLTY23
0
5
13
Dr @manalipatelmd "physicians should not be dictating what patients should want at the end of life" #ASCOQLTY23
3
8
44
Ms Emily Hayes Wood, BA, MPH presents at #ASCOQLTY23 on how community-academic partnerships can help overcome community-identified needs for marginalized populations 1⃣100% completed treatment 2⃣dx to tx time 83 ➡️ 43 days 3⃣34% actively participated in a #clinicaltrial
0
6
14